WNT-5A, but not matrix metalloproteinase 3 or β-catenin protein, expression is related to early stages of lip carcinogenesis

Journal of Oral Pathology and Medicine

Volumn 38, Issue 9, 2009, Pages 708-715

  Xavier, Flávia Caló Aquino ^a,c   Rodini, Camila Oliveira ^a   Ramalho, Luciana Maria Pedreira ^b   Mantesso, Andrea ^a   Nunes, Fabio Daumas ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Praia do Castelo   (Brazil)

Author keywords

catenin; Actinic cheilitis; MMP 3; Squamous cell carcinoma; WNT 5A protein

Indexed keywords

BETA CATENIN; STROMELYSIN; WNT5A PROTEIN;

ACTINIC CHEILITIS; ANTIBODY LABELING; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELLULAR DISTRIBUTION; CHEILITIS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIP CARCINOMA; LIP SQUAMOUS CELL CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CHEILITIS; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LIP NEOPLASMS; MATRIX METALLOPROTEINASE 3; MOUTH MUCOSA; PROTO-ONCOGENE PROTEINS; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; SUNLIGHT; TUMOR MARKERS, BIOLOGICAL; WNT PROTEINS;

EID: 70350334601     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00756.x     Document Type: Article

References (43)

1. Chidzonga MM. Oral malignant neoplasia: a survey of 428 cases in two Zimbabwean hospitals. Oral Oncol 2006; 42: 177-183
2. de Rosa I, Staibano S, Lo Muzio L, et al. Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferation cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med 1999; 28: 252-258
3. Moore S, Johnson N, Pierce A, Wilson D. The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis 1999; 5: 185-195
4. Picascia DD, Robinson JK. Actinics cheiliti: a review of the etiology, differential diagnosis and treatment. J Am Acad Dermatol 1987; 17: 255-264
5. Kaugars GE, Pillion T, Svirsky JA, Page DG, Burns JC, Abbey LM. Actinic cheilitis: a review of 152 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 181-186
6. van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol, in press (doi: 10.1016/j.oraloncology.2008.05.016).
7. dos Santos JN, Sousa SOM, Nunes FD, Sotto MN, Araújo VC. Altered cytokeratin expression in actinic cheilitis. J Cutan Pathol 2003; 30: 237-241
8. Fabbrocini G, Russo N, Pagliuca MC, et al. p53, cyclin- D1, PCNA, AgNOR expression in squamous cell cancer of the lip: a multicenter study. Photodermatol Photoimmunol Photomed 2000; 16: 172-177
9. Fillies T, Buerger H, Gaertner C, et al. Catenin expression in T1 / 2 carcinomas of the floor of the mouth. Int J Oral Maxillofac Surg 2005; 34: 907-911
10. Uraguchi M, Morikawa M, Shirakawa M, Sanada K, Imai K. Activation of WNT family expression and signaling in squamous cell carcinomas of the oral cavity. J Dent Res 2004; 83: 327-332 (Pubitemid 41713770)
11. Clark CC, Cohen I, Eichstetter I, et al. Molecular cloning of the human proto-oncogene WNT-5A and Mapping of the gene (WNT5A) to chromosome 3p14-p21. Genomics 1993; 18: 249-260
12. Huang C, Liu D, Nakano J, et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor-an expression in nonsmall-cell lung cancer. J Clin Oncol 2005; 23: 8765-8773
13. Prieve MG, Moon RT. Stromelysin-1 and mesothelin are differentially regulated by WNT-5A and Wnt-1 in C57mg mouse mammary epithelial cells. BMC Dev Biol 2003; 3: 2.
14. Katoh M. WNT/ PCP signaling pathway and human cancer (Review). Oncol Rep 2005; 14: 1583-1588
15. Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-642
16. Kühl M. The WNT/ calcium pathway: biochemical mediators, tools and future requirements. Front Biosci 2004; 9: 967-974
17. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M. Down-regulation of Wnt-4 and upregulation of WNT-5A expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 2003; 94: 593-597
18. Vincan E. Frizzled /WNT signalling: the insidious promoter of tumour growth and progression. Front Biosci 2004; 9: 1023-1034
19. Pukrop T, Binder C. The complex pathways of Wnt 5a in cancer progression. J Mol Med 2008; 86: 259-266
20. Demir-Weustena AY, Sevalb Y, Kaufmannc P, Demirb R, Yuceld G, Huppertze B. Matrix metalloproteinases-2, -3 and -9 in human term placenta. Acta Histochem 2007; 109: 403-412
21. Kusukawa J, Sasaguri Y, Morimatsu M, Kameyama T. Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 1995; 53: 530-534
22. Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer. Oral Oncol 1999; 35: 227-233
23. Horváth B, Hegyesi H, Nagy P, Falus A, Schaff Z. Expression of ets-1 transcription factor in human head and neck squamous cell carcinoma and effect of histamine on metastatic potential of invasive tumor through the regulation of expression of ets-1 and matrix metalloproteinase- 3. Head Neck 2005; 27: 585-596
24. Erdem NF, Carlson ER, Gerard DA, Ichiki AT. Carcinoma cell lines with different invasion and / or metastatic potentials. J Oral Maxillofac Surg 2007; 65: 1725-1733
25. McCawley LJ, Crawford HC, King LE Jr, Mudgett J, Matrisian LM. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res 2004; 64: 6965-6972
26. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 2006; 42: 987-993
27. Cardesa A, Gale N, Nadao A, Zidar N. Squamous cell carcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and genetics of head and neck tumours. Lyon: IARC Press, 2005; 120-123
28. Ogbureke KUE, Nikitakis NG, Warburton G, et al. Upregulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer. Oral Oncol 2007; 43: 920-932
29. Kotsinas A, Evangelou K, Zacharatos P, et al. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas. Am J Pathol 2002; 61: 1619-1634
30. Martínez A, Brethauer U, Borlando J, Spencer ML, Rojas IG. Epithelial expression of p53, mdm-2 and p21 in normal lip and actinic cheilitis. Oral Oncol 2008; 44: 878-883
31. Martínez A, Brethauer U, Rojas IG, et al. Expression of apoptotic and cell proliferation regulatory proteins in actinic cheilitis. J Oral Pathol Med 2005; 34: 257-262
32. Danielson KG, Pillarisetti J, Cohen IR, et al. Characterization of the complete genomic structure of the human WNT-5A gene, functional analysis of its promoter, chromosomal mapping, and expression in early human embryogenesis. J Biol Chem 1995; 270: 31225-31234
33. Dejmek J, Dejmek A, Säfholm A, Sjölander A, Andersson T. WNT-5A protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 2005; 65: 9142-9146
34. Leandersson K, Riesbeck K, Andersson T. WNT-5A mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells. Nucleic Acids Res 2006; 34: 3988-3999
35. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-tomesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997; 139: 1861-1872
36. Tsukifuji R, Tagawa K, Hatamochi A, Shinkai H. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis. Br J Cancer 1999; 80: 1087-1091
37. He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H. A member of the Frizzled protein family mediating axis induction by WNT-5A. Science 1997; 275:1652-1654
38. Nabais S, Machado JC, Lopes C, Seruca R, Carneiro F, Sobrinho-Simoes M. Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis. Int J Surg Pathol 2003; 11: 1-9.
39. Ninomiya I, Endo Y, Fushida S, et al. Alteration of betacatenin expression in esophageal squamous-cell carcinoma. Int J Cancer 2000; 85: 757-761
40. Brasanac D, Boricic I, Todorovic V, Tomanovic N, Radojevic S. Cyclin A and b-catenin expression in actinickeratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Br J Dermatol 2005; 153: 1166-1175
41. Impola U, Uitto VJ, Hietanen J, et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004; 202: 14-22.
42. Wiegand S, Dünne AA, Müller HH, et al. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer 2005; 104: 94-100.
43. Abreu MA, Silva OM, Neto Pimentel DR, et al. Actinic cheilitis adjacent to squamous carcinoma of the lips as an indicator of prognosis. Rev Bras Otorrinolaringol 2006; 72: 767-771.